Literature DB >> 21483437

Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism.

S Villafuerte1, M M Heitzeg, S Foley, W-Y Wendy Yau, K Majczenko, J-K Zubieta, R A Zucker, M Burmeister.   

Abstract

Genetic factors, externalizing personality traits such as impulsivity, and brain processing of salient stimuli all can affect individual risk for alcoholism. One of very few confirmed genetic association findings differentiating alcoholics from non-alcoholics is with variants in the inhibitory γ-amino butyric acid α2 receptor subunit (GABRA2) gene. Here we report the association of two of these GABRA2 variants with measures of alcohol symptoms, impulsivity and with insula cortex activation during anticipation of reward or loss using functional magnetic resonance imaging (fMRI). In a sample of 173 families (449 subjects), 129 of whom had at least one member diagnosed with alcohol dependence or abuse, carriers for the G allele in two single-nucleotide polymorphisms (SNPs) and haplotypes were more likely to have alcohol dependence symptoms (rs279858, P=0.01; rs279826, P=0.05; haplotype, P=0.02) and higher NEO Personality Inventory-Revised (NEO-PI-R) Impulsiveness scores (rs279858, P=0.016; rs279826, P=0.012; haplotype, P=0.032) with a stronger effect in women (rs279858, P=0.011; rs279826, P=0.002; haplotype, P=0.006), all P-values are corrected for family history and age. A subset of offspring from these families (n=44, 20 females), genotyped for GABRA2, participated in an fMRI study using a monetary incentive delay task. Increased insula activation during reward (r(2)=0.4; P=0.026) and loss (r(2)=0.38; P=0.039) anticipation was correlated with NEO-PI-R Impulsiveness and further associated with the GG genotype for both SNPs (P's<0.04). Our results suggest that GABRA2 genetic variation is associated with Impulsiveness through variation of insula activity responses, here evidenced during anticipatory responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21483437      PMCID: PMC3166450          DOI: 10.1038/mp.2011.33

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  48 in total

1.  Fast, iterative image reconstruction for MRI in the presence of field inhomogeneities.

Authors:  Bradley P Sutton; Douglas C Noll; Jeffrey A Fessler
Journal:  IEEE Trans Med Imaging       Date:  2003-02       Impact factor: 10.048

2.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

3.  Precentral gyrus discrepancy in electronic versions of the Talairach atlas.

Authors:  Joseph A Maldjian; Paul J Laurienti; Jonathan H Burdette
Journal:  Neuroimage       Date:  2004-01       Impact factor: 6.556

4.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.

Authors:  Joseph A Maldjian; Paul J Laurienti; Robert A Kraft; Jonathan H Burdette
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

5.  Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse.

Authors:  Sharon Dawe; Matthew J Gullo; Natalie J Loxton
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

6.  Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats.

Authors:  M Gulinello; S S Smith
Journal:  J Pharmacol Exp Ther       Date:  2003-02-11       Impact factor: 4.030

7.  Allelic and haplotypic association of GABRA2 with alcohol dependence.

Authors:  Jonathan Covault; Joel Gelernter; Victor Hesselbrock; Maggie Nellissery; Henry R Kranzler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-08-15       Impact factor: 3.568

8.  Role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring.

Authors:  Danielle M Dick; Shawn J Latendresse; Jennifer E Lansford; John P Budde; Alison Goate; Kenneth A Dodge; Gregory S Pettit; John E Bates
Journal:  Arch Gen Psychiatry       Date:  2009-06

9.  Resting EEG in offspring of male alcoholics: beta frequencies.

Authors:  Madhavi Rangaswamy; Bernice Porjesz; David B Chorlian; Kongming Wang; Kevin A Jones; Samuel Kuperman; John Rohrbaugh; Sean J O'Connor; Lance O Bauer; Theodore Reich; Henri Begleiter
Journal:  Int J Psychophysiol       Date:  2004-02       Impact factor: 2.997

10.  Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations.

Authors:  Howard J Edenberg; Danielle M Dick; Xiaoling Xuei; Huijun Tian; Laura Almasy; Lance O Bauer; Raymond R Crowe; Alison Goate; Victor Hesselbrock; Kevin Jones; Jennifer Kwon; Ting-Kai Li; John I Nurnberger; Sean J O'Connor; Theodore Reich; John Rice; Marc A Schuckit; Bernice Porjesz; Tatiana Foroud; Henri Begleiter
Journal:  Am J Hum Genet       Date:  2004-03-12       Impact factor: 11.025

View more
  73 in total

Review 1.  Genetics of alcoholism.

Authors:  Priya A Iyer-Eimerbrink; John I Nurnberger
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

2.  Temperament and externalizing behavior as mediators of genetic risk on adolescent substance use.

Authors:  Elisa M Trucco; Brian M Hicks; Sandra Villafuerte; Joel T Nigg; Margit Burmeister; Robert A Zucker
Journal:  J Abnorm Psychol       Date:  2016-02-04

3.  Examination of genetic variation in GABRA2 with conduct disorder and alcohol abuse and dependence in a longitudinal study.

Authors:  Whitney E Melroy; Sarah H Stephens; Joseph T Sakai; Helen M Kamens; Matthew B McQueen; Robin P Corley; Michael C Stallings; Christian J Hopfer; Kenneth S Krauter; Sandra A Brown; John K Hewitt; Marissa A Ehringer
Journal:  Behav Genet       Date:  2014-04-01       Impact factor: 2.805

Review 4.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

5.  Rsu1 regulates ethanol consumption in Drosophila and humans.

Authors:  Shamsideen A Ojelade; Tianye Jia; Aylin R Rodan; Tao Chenyang; Julie L Kadrmas; Anna Cattrell; Barbara Ruggeri; Pimphen Charoen; Hervé Lemaitre; Tobias Banaschewski; Christian Büchel; Arun L W Bokde; Fabiana Carvalho; Patricia J Conrod; Herta Flor; Vincent Frouin; Jürgen Gallinat; Hugh Garavan; Penny A Gowland; Andreas Heinz; Bernd Ittermann; Mark Lathrop; Steven Lubbe; Jean-Luc Martinot; Tomás Paus; Michael N Smolka; Rainer Spanagel; Paul F O'Reilly; Jaana Laitinen; Juha M Veijola; Jianfeng Feng; Sylvane Desrivières; Marjo-Riitta Jarvelin; Gunter Schumann; Adrian Rothenfluh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 6.  GABAA receptor polymorphisms in alcohol use disorder in the GWAS era.

Authors:  Mairi Koulentaki; Elias Kouroumalis
Journal:  Psychopharmacology (Berl)       Date:  2018-05-02       Impact factor: 4.530

7.  Rule breaking mediates the developmental association between GABRA2 and adolescent substance abuse.

Authors:  Elisa M Trucco; Sandra Villafuerte; Mary M Heitzeg; Margit Burmeister; Robert A Zucker
Journal:  J Child Psychol Psychiatry       Date:  2014-05-09       Impact factor: 8.982

Review 8.  Genetic influences on the development of alcoholism.

Authors:  Mary-Anne Enoch
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

9.  Nucleus accumbens, thalamus and insula connectivity during incentive anticipation in typical adults and adolescents.

Authors:  Youngsun T Cho; Stephen Fromm; Amanda E Guyer; Allison Detloff; Daniel S Pine; Julie L Fudge; Monique Ernst
Journal:  Neuroimage       Date:  2012-10-13       Impact factor: 6.556

Review 10.  Genetics and alcoholism.

Authors:  Howard J Edenberg; Tatiana Foroud
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-05-28       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.